CEFERD
Research at CEFERD
Our Mission
Our Vision
Core Values
Our Purpose
Our Studies
- DIFFCOV Study
- The ARS Study
- The Neurocognitive Study
- TPT Study
- Completed Studies
Mitigating the Effects of COVID-19 Pandemic on Antenatal Attendance in Kisumu County: Leveraging Technology and Point of Care Diagnostics to deliver Differentiated Care (DiffCov) and integrated suite of digital tools and artificial intelligence for antenatal pregnancy risk stratification in sub-Saharan Africa (DiffCov study) DiffCov was a targeted intervention project focused on sustaining and improving maternal health services during the COVID-19 disruptions in Kisumu County, Kenya
Completed in 2022. The organizational profile lists SWAP and the Bill & Melinda Gates Foundation as funders or partners.
The ARS study: Validation of Artificial Intelligence-Developed Maternal, Infant Health Insights and Cognitive Intelligence (MIHICTM) Scores for Antenatal Pregnancy Risk Stratification in Low Resource Settings is a validation-focused research project evaluating the performance of an AI-driven scoring system for early pregnancy risk assessment in resource-constrained environments, particularly in sub-Saharan Africa.
Completed in 2025. The organizational profile lists SWAP, the Bill & Melinda Gates Foundation and the REEN Foundation as funders or partners.
The Neurocognitive Study : Effect of Maternal Psychological Health and Malnutrition on Cognitive Function in Children at Jaramogi Oginga Odinga Teaching and Referral Hospital. The study was a research initiative examining the interplay between maternal mental health, child malnutrition, and neurocognitive development in young children attending Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH) in Kisumu County, Kenya (2023).
Completed in 2024. The Neurocognitive Study forms part of CEFERD’s completed clinical and public health research portfolio. Contact the team for study enquiries.
The TPT Study is part of CEFERD’s completed research portfolio. The study was completed in 2025.
CEFERD conducts and supports clinical and observational research through coordinated clinical, pharmacy, laboratory, data and administrative teams. Contact us for information about the study.
CEFERD’s completed portfolio includes DiffCov (2022), ARS, EDAN and TPT (2025), and IPT, SOUND and Neurocognitive studies (2024).
Our research brings together clinical, public health and epidemiological expertise. Explore the portfolio or contact CEFERD for study enquiries.
Kulindana Study
Ongoing in the August 2026 portfolio; started May 2026. The organizational profile lists the University of Washington–Kenya as a partner.
ACT TPT Study
ACT-TPT is listed among CEFERD’s upcoming or planned studies in the August 2026 organizational profile. Contact the team for study enquiries.
SMARTMAL DX
Refinement and Practical Clinical Validation of the Rapid Malaria Artificial Intelligence (AI) Processing Tool for Detection of Plasmodium falciparum in Thin Blood Smear Images from Resource-Limited Health Settings
SPOT-TCD
Ongoing in the August 2026 portfolio; started July 2026. The study forms part of CEFERD’s clinical and public health research programme.
HIVE Study
Planned study, as listed in CEFERD’s August 2026 organizational profile. Contact CEFERD for study information and collaboration enquiries.
MOBUS Study
Ongoing in CEFERD’s August 2026 portfolio. Prospective clinical data collection for developing machine learning-assisted obstetric ultrasound screening algorithms in low- and middle-income countries.
The SOUND Study
Completed in 2024. The organizational profile lists the Novartis Foundation as a funder or partner for the SOUND Study.
POCUS Study
Ongoing in CEFERD’s August 2026 portfolio. Development and validation of AI-powered algorithms for point-of-care obstetric ultrasound scanning in low-resource settings.
Kenya HIUD Scale-Up Baseline Assessment
Ongoing in CEFERD’s August 2026 portfolio. Baseline assessment supporting increased access to hormonal intrauterine devices in Kenya.
Studies at CEFERD
- ARS Study
- Diffcov Study
- TPT Study
- SMARTMAL DX Study
- IPT Study
- The SOUND Study
- Neurocognitive Study
- MOBUS Study
- POCUS Study
- Kenya HUID Scale Up Baseline Assessment
- HIVE Study
- Kulindana Study
- SPOT TCD
- ACT TPT Study
Clinical, Public Health
and Epidemiological Research
Five coordinated departments support safe, ethical and scientifically rigorous research at CEFERD.
The Centre for Family Health Research and Development (CEFERD), based at Jaramogi Oginga Odinga Teaching and Referral Hospital in Kisumu, is dedicated to advancing family and community health through evidence‑based research, innovation, and sustainable interventions. Guided by integrity, excellence, collaboration, equity, and impact, CEFERD strives to be a leading centre of excellence that generates knowledge to inform policy, strengthen health systems, and empower communities. Its purpose is to bridge research and practice, transforming data into action that creates healthier, more resilient families and communities across Kenya and beyond.
Contact Us P.O Box 3670 – 40100, Kisumu Tell: +254‑110 720 696 Email: info@ceferd.org / ceferdresearch
Ceferd Journal
Lacinia eget consecte sed convallis.
Quasi architebeatae vitae dicta sunt explicabo nemo enim ipsam volupatem quia voluptassit asper natur aut ...
Haematopoietic stem cell transplant.
Quasi architebeatae vitae dicta sunt explicabo nemo enim ipsam volupatem quia voluptassit asper natur aut ...
Excepteur sint occaecat cupidatat.
Quasi architebeatae vitae dicta sunt explicabo nemo enim ipsam volupatem quia voluptassit asper natur aut ...
“At CEFERD, we believe that rigorous research is not just about generating data—it is about transforming lives. Every study we undertake is guided by the conviction that evidence must inform action, and that families and communities deserve health solutions rooted in science, compassion, and sustainability.”
Contact Us
CEFERD About us: Located at Jaramogi Oginga Odinga Teaching and Referral Hospital along Kakamega Road – Kisumu.
Contact: P.O Box 3670 – 40100, Kisumu Tell: +254-110 720 696 Email: info@ceferd.org / ceferdresearch@gmail.com
Twitter : @CEFERD_ORG